Search
Cryoport Inc
CYRXAdd to Watchlist
13.140USD
-0.090-0.68%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
659.60MMarket Cap
9.17P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-0.68%
5 Days
-3.38%
1 Month
+29.20%
6 Months
+51.56%
Year to Date
+36.88%
1 Year
+96.71%
TradingKey Stock Score of Cryoport Inc
Currency: USD Updated: 2026-05-15Key Insights
Cryoport Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 9 out of 75 in the Freight & Logistics Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.35.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cryoport Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Cryoport Inc Highlights
StrengthsRisks
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PB is 1.46, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.22M shares, decreasing 18.53% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 76.27K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.12.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
14.350
Target Price
+8.47%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cryoport Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cryoport Inc Info
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Ticker SymbolCYRX
CompanyCryoport Inc
CEOShelton (Jerrell Wilson)
Websitehttps://www.cryoport.com/
Related Instruments
+0.45%
-1.09%
-0.57%
+0.53%
-2.11%
-0.24%
-0.58%
-1.84%
+2.17%
-3.30%
-3.35%
+2.96%
-0.61%
+1.20%
+2.38%
-2.14%
-0.52%
-4.76%
+0.24%
-1.13%Popular Instruments
102.160
+3.297 (+3.33%)
300.230
+2.020 (+0.68%)
225.320
-10.420 (-4.42%)
4538.710
-111.520 (-2.40%)
482.020
-7.101 (-1.45%)
1407.610
+24.890 (+1.80%)
724.660
-51.350 (-6.62%)
396.780
-4.290 (-1.07%)
77994.580
-236.420 (-0.30%)
422.240
-21.060 (-4.75%)
